D68.31 – Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Child Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
| D65-D69 | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
| D68 | Other coagulation defects |
| D68.3 | Hemorrhagic disorder due to circulating anticoagulants |
| D68.31 | Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.311 | Acquired hemophilia |
| D68.312 | Antiphospholipid antibody with hemorrhagic disorder |
| D68.318 | Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |